392. Evaluating Promoter Regulated Dopaminergic Neuron Targeting With AAV9 Delivered to the Neonatal Mouse
Molecular Therapy - United States
doi 10.1016/s1525-0016(16)34001-1
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2015
Authors
Publisher
Elsevier BV